{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:36:33Z","timestamp":1794645393663,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1038\/s41593-021-00936-z","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T11:02:46Z","timestamp":1635418966000},"page":"1534-1541","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis"],"prefix":"10.1038","volume":"24","author":[{"given":"Iddo","family":"Magen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5152-8775","authenticated-orcid":false,"given":"Nancy Sarah","family":"Yacovzada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Yanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Coenen-Stass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Grosskreutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Greensmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8020-7567","authenticated-orcid":false,"given":"Andrea","family":"Malaspina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8762-8188","authenticated-orcid":false,"given":"Pietro","family":"Fratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5534-1924","authenticated-orcid":false,"given":"Eran","family":"Hornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"key":"936_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1212\/WNL.38.3.409","volume":"38","author":"TL Munsat","year":"1988","unstructured":"Munsat, T. L., Andres, P. L., Finison, L., Conlon, T. & Thibodeau, L. The natural history of motoneuron loss in amyotrophic lateral sclerosis. Neurology 38, 409\u2013413 (1988).","journal-title":"Neurology"},{"key":"936_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1212\/WNL.0b013e3181b6bbbd","volume":"73","author":"JM Ravits","year":"2009","unstructured":"Ravits, J. M. & La Spada, A. R. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 73, 805\u2013811 (2009).","journal-title":"Neurology"},{"key":"936_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mus.24979","volume":"53","author":"M Benatar","year":"2016","unstructured":"Benatar, M. et al. ALS biomarkers for therapy development: state of the field and future directions. Muscle Nerve 53, 169\u2013182 (2016).","journal-title":"Muscle Nerve"},{"key":"936_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fneur.2019.00229","volume":"10","author":"RH Chipika","year":"2019","unstructured":"Chipika, R. H., Finegan, E., Li Hi Shing, S., Hardiman, O. & Bede, P. Tracking a fast-moving disease: longitudinal markers, monitoring, and clinical trial endpoints in ALS. Front. Neurol. 10, 229 (2019).","journal-title":"Front. Neurol."},{"key":"936_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fneur.2019.00291","volume":"10","author":"NS Verber","year":"2019","unstructured":"Verber, N. S. et al. Biomarkers in motor neuron disease: a state of the art review. Front. Neurol. 10, 291 (2019).","journal-title":"Front. Neurol."},{"key":"936_CR6","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00415-017-8730-6","volume":"265","author":"D Rossi","year":"2018","unstructured":"Rossi, D. et al. CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis. J. Neurol. 265, 510\u2013521 (2018).","journal-title":"J. Neurol."},{"key":"936_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/21678421.2016.1212894","volume":"18","author":"M Goncalves","year":"2017","unstructured":"Goncalves, M. et al. Phosphoneurofilament heavy chain and vascular endothelial growth factor as cerebrospinal fluid biomarkers for ALS. Amyotroph. Lateral Scler. Frontotemporal Degener. 18, 134\u2013136 (2017).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"936_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/jnnp-2014-307672","volume":"86","author":"CH Lu","year":"2015","unstructured":"Lu, C. H. et al. Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study. J. Neurol. Neurosurg. Psychiatry 86, 565\u2013573 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"936_CR9","doi-asserted-by":"publisher","first-page":"3023826","DOI":"10.1155\/2018\/3023826","volume":"2018","author":"MT Gonzalez-Garza","year":"2018","unstructured":"Gonzalez-Garza, M. T., Martinez, H. R., Cruz-Vega, D. E., Hernandez-Torre, M. & Moreno-Cuevas, J. E. Adipsin, MIP-1b, and IL-8 as CSF biomarker panels for ALS diagnosis. Dis. Markers 2018, 3023826 (2018).","journal-title":"Dis. Markers"},{"key":"936_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jns.2018.08.033","volume":"394","author":"LGR Prado","year":"2018","unstructured":"Prado, L. G. R. et al. Longitudinal assessment of clinical and inflammatory markers in patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 394, 69\u201374 (2018).","journal-title":"J. Neurol. Sci."},{"key":"936_CR11","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1212\/NXI.0000000000000244","volume":"3","author":"CH Lu","year":"2016","unstructured":"Lu, C. H. et al. Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 3, e244 (2016).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"936_CR12","doi-asserted-by":"publisher","first-page":"13111","DOI":"10.1073\/pnas.1006151107","volume":"107","author":"S Haramati","year":"2010","unstructured":"Haramati, S. et al. miRNA malfunction causes spinal motor neuron disease. Proc. Natl Acad. Sci. USA 107, 13111\u201313116 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"936_CR13","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.15252\/embj.201490493","volume":"34","author":"A Emde","year":"2015","unstructured":"Emde, A. et al. Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS. EMBO J. 34, 2633\u20132651 (2015).","journal-title":"EMBO J."},{"key":"936_CR14","doi-asserted-by":"crossref","unstructured":"Eitan, C. & Hornstein, E. Vulnerability of microRNA biogenesis in FTD\u2013ALS. Brain Res. 1647, 105\u2013111 (2016).","DOI":"10.1016\/j.brainres.2015.12.063"},{"key":"936_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-015-0161-7","volume":"8","author":"I Takahashi","year":"2015","unstructured":"Takahashi, I. et al. Identification of plasma microRNAs as a biomarker of sporadic amyotrophic lateral sclerosis. Mol. Brain 8, 67 (2015).","journal-title":"Mol. Brain"},{"key":"936_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jns.2016.06.046","volume":"368","author":"HM de Andrade","year":"2016","unstructured":"de Andrade, H. M. et al. MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis. J. Neurol. Sci. 368, 19\u201324 (2016).","journal-title":"J. Neurol. Sci."},{"key":"936_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13195-017-0316-0","volume":"9","author":"KS Sheinerman","year":"2017","unstructured":"Sheinerman, K. S. et al. Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases. Alzheimers Res. Ther. 9, 89 (2017).","journal-title":"Alzheimers Res. Ther."},{"key":"936_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41420-020-00397-6","volume":"7","author":"G Dobrowolny","year":"2021","unstructured":"Dobrowolny, G. et al. A longitudinal study defined circulating microRNAs as reliable biomarkers for disease prognosis and progression in ALS human patients. Cell Death Discov. 7, 4 (2021).","journal-title":"Cell Death Discov."},{"key":"936_CR19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s12017-016-8396-8","volume":"18","author":"M Benigni","year":"2016","unstructured":"Benigni, M. et al. Identification of miRNAs as potential biomarkers in cerebrospinal fluid from amyotrophic lateral sclerosis patients. Neuromolecular Med. 18, 551\u2013560 (2016).","journal-title":"Neuromolecular Med."},{"key":"936_CR20","first-page":"1133","volume":"15","author":"AML Coenen-Stass","year":"2018","unstructured":"Coenen-Stass, A. M. L. et al. Evaluation of methodologies for microRNA biomarker detection by next generation sequencing. RNA Biol. 15, 1133\u20131145 (2018).","journal-title":"RNA Biol."},{"key":"936_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cmpb.2019.05.023","volume":"177","author":"M Og\u0142uszka","year":"2019","unstructured":"Og\u0142uszka, M., Orzechowska, M., J\u0119droszka, D., Witas, P. & Bednarek, A. K. Evaluate Cutpoints: adaptable continuous data distribution system for determining survival in Kaplan\u2013Meier estimator. Comput. Methods Prog. Biomed. 177, 133\u2013139 (2019).","journal-title":"Comput. Methods Prog. Biomed."},{"key":"936_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1198\/0003130043277","volume":"58","author":"PC Austin","year":"2004","unstructured":"Austin, P. C. & Tu, J. V. Bootstrap methods for developing predictive models. Am. Statistician 58, 131\u2013137 (2004).","journal-title":"Am. Statistician"},{"key":"936_CR23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1474-4422(18)30089-9","volume":"17","author":"HJ Westeneng","year":"2018","unstructured":"Westeneng, H. J. et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 17, 423\u2013433 (2018).","journal-title":"Lancet Neurol."},{"key":"936_CR24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/hbm.25258","volume":"42","author":"R Steinbach","year":"2021","unstructured":"Steinbach, R. et al. Disease aggressiveness signatures of amyotrophic lateral sclerosis in white matter tracts revealed by the D50 disease progression model. Hum. Brain Mapp. 42, 737\u2013752 (2021).","journal-title":"Hum. Brain Mapp."},{"key":"936_CR25","doi-asserted-by":"publisher","first-page":"eaav5264","DOI":"10.1126\/scitranslmed.aav5264","volume":"11","author":"I Reichenstein","year":"2019","unstructured":"Reichenstein, I. et al. Human genetics and neuropathology suggest a link between miR-218 and amyotrophic lateral sclerosis pathophysiology. Sci. Transl. Med. 11, eaav5264 (2019).","journal-title":"Sci. Transl. Med."},{"key":"936_CR26","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1093\/nar\/gkw116","volume":"44","author":"N Ludwig","year":"2016","unstructured":"Ludwig, N. et al. Distribution of miRNA expression across human tissues. Nucleic Acids Res. 44, 3865\u20133877 (2016).","journal-title":"Nucleic Acids Res."},{"key":"936_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil, M. et al. Neurofilaments as biomarkers in neurological disorders. Nat. Rev. Neurol. 14, 577\u2013589 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"936_CR28","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","volume":"84","author":"CH Lu","year":"2015","unstructured":"Lu, C. H. et al. Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis. Neurology 84, 2247\u20132257 (2015).","journal-title":"Neurology"},{"key":"936_CR29","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3389\/fneur.2018.01167","volume":"9","author":"K Poesen","year":"2018","unstructured":"Poesen, K. & Van Damme, P. Diagnostic and prognostic performance of neurofilaments in ALS. Front. Neurol. 9, 1167 (2018).","journal-title":"Front. Neurol."},{"key":"936_CR30","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1212\/WNL.0000000000009559","volume":"95","author":"M Benatar","year":"2020","unstructured":"Benatar, M. et al. Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS. Neurology 95, e59\u2013e69 (2020).","journal-title":"Neurology"},{"key":"936_CR31","doi-asserted-by":"publisher","first-page":"e102513","DOI":"10.15252\/embj.2019102513","volume":"39","author":"E Corradi","year":"2020","unstructured":"Corradi, E. et al. Axonal precursor miRNAs hitchhike on endosomes and locally regulate the development of neural circuits. EMBO J. 39, e102513 (2020).","journal-title":"EMBO J."},{"key":"936_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1126\/science.1091903","volume":"303","author":"C-Z Chen","year":"2004","unstructured":"Chen, C.-Z., Li, L., Lodish, H. F. & Bartel, D. P. MicroRNAs modulate hematopoietic lineage differentiation. Science 303, 83 (2004).","journal-title":"Science"},{"key":"936_CR33","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ana.25276","volume":"84","author":"M Benatar","year":"2018","unstructured":"Benatar, M., Wuu, J., Andersen, P. M., Lombardi, V. & Malaspina, A. Neurofilament light: a candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion. Ann. Neurol. 84, 130\u2013139 (2018).","journal-title":"Ann. Neurol."},{"key":"936_CR34","doi-asserted-by":"crossref","unstructured":"Puentes, F. et al. Immune reactivity to neurofilaments and dipeptide repeats in ALS progression. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2020.02.25.965236v1 (2020).","DOI":"10.1101\/2020.02.25.965236"},{"key":"936_CR35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1136\/jnnp-2013-305494","volume":"85","author":"F Puentes","year":"2014","unstructured":"Puentes, F. et al. Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 85, 274\u2013278 (2014).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"936_CR36","doi-asserted-by":"crossref","unstructured":"Brooks, B. R., Miller, R. G., Swash, M., Munsat, T. L. & World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 1, 293\u2013299 (2000).","DOI":"10.1080\/146608200300079536"},{"key":"936_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","volume":"169","author":"JM Cedarbaum","year":"1999","unstructured":"Cedarbaum, J. M. et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J. Neurol. Sci. 169, 13\u201321 (1999).","journal-title":"J. Neurol. Sci."},{"key":"936_CR38","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","volume":"88","author":"K Poesen","year":"2017","unstructured":"Poesen, K. et al. Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology 88, 2302\u20132309 (2017).","journal-title":"Neurology"},{"key":"936_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fnagi.2019.00005","volume":"11","author":"T Prell","year":"2019","unstructured":"Prell, T. et al. Reaction to endoplasmic reticulum stress via ATF6 in amyotrophic lateral sclerosis deteriorates with aging. Front. Aging Neurosci. 11, 5 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"936_CR40","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12859-019-2728-2","volume":"24","author":"R Kohen","year":"2019","unstructured":"Kohen, R. et al. UTAP: user-friendly transcriptome analysis pipeline. BMC Bioinformatics 24, 154 (2019).","journal-title":"BMC Bioinformatics"},{"key":"936_CR41","doi-asserted-by":"publisher","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","volume":"42","author":"A Kozomara","year":"2014","unstructured":"Kozomara, A. & Griffiths-Jones, S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 42, D68\u2013D73 (2014).","journal-title":"Nucleic Acids Res."},{"key":"936_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"936_CR43","doi-asserted-by":"crossref","first-page":"e1205","DOI":"10.1212\/WNL.0000000000007097","volume":"92","author":"V Lombardi","year":"2019","unstructured":"Lombardi, V. et al. Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy. Neurology 92, e1205\u2013e1211 (2019).","journal-title":"Neurology"},{"key":"936_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14836","volume":"8","author":"T Peng","year":"2017","unstructured":"Peng, T. et al. A BaSiC tool for background and shading correction of optical microscopy images. Nat. Commun. 8, 14836 (2017).","journal-title":"Nat. Commun."},{"key":"936_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-10-r106","volume":"11","author":"S Anders","year":"2010","unstructured":"Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).","journal-title":"Genome Biol."},{"key":"936_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","volume":"125","author":"Y Benjamini","year":"2001","unstructured":"Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N. & Golani, I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125, 279\u2013284 (2001).","journal-title":"Behav. Brain Res."},{"key":"936_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/sim.4780030207","volume":"3","author":"FE Harrell Jr.","year":"1984","unstructured":"Harrell, F. E. Jr., Lee, K. L., Califf, R. M., Pryor, D. B. & Rosati, R. A. Regression modelling strategies for improved prognostic prediction. Stat. Med. 3, 143\u2013152 (1984).","journal-title":"Stat. Med."},{"key":"936_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00401706.1969.10490657","volume":"11","author":"FE Grubbs","year":"1969","unstructured":"Grubbs, F. E. Procedures for detecting outlying observations in samples. Technometrics 11, 1\u201321 (1969).","journal-title":"Technometrics"},{"key":"936_CR49","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2015)."}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-021-00936-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-021-00936-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-021-00936-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T19:35:54Z","timestamp":1725996954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-021-00936-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["936"],"URL":"https:\/\/doi.org\/10.1038\/s41593-021-00936-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-554057\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/833079","asserted-by":"object"}]},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,28]]},"assertion":[{"value":"23 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}